Study reaches no conclusion on IV omeprazole for GI bleeding

11/26/2012 | Medscape (free registration)

Critically ill children given intravenous omeprazole at two dosage levels showed increased gastric pH, but researchers in Spain said it was not clear whether that reduced gastrointestinal bleeding or increased the risk of infection. Omeprazole is used to reduce bleeding risks but an effective IV dose in children has not been established.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
Washington DC, DC